Endovia Health Sciences, Inc.
EDVA· NYSE
Filed Nov 19, 2014 · 10-Q · 50 days after period end · 0001079973-14-000586
| Metric | Q3 2014 | Q3 2013 | Q3 2012 |
|---|---|---|---|
| Revenue | $139.74K | $141.85K | $89.65K |
| Net Income | -$6.64K | -$11.16K | $3.00K |
| EPS Diluted | $0.00 | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Endovia Health Sciences, Inc. · CIK 1553788 · Engraved from SEC EDGAR
ended Sep 30, 2014 · filed Nov 19, 2014 · 50 d after period end